Close menu




April 4th, 2024 | 08:00 CEST

+100% and more with momentum stocks: AIXTRON, BASF, Exasol

  • Software
  • Technology
  • chemicals
  • AI
Photo credits: pixabay.com

Surprise! BASF shares have gained around 25% since mid-January. And the momentum could continue. Analysts see further upside potential. But there are also skeptical voices. In contrast, the Exasol share has only just taken off. The German AI hopeful has reported orders, the share has left the downward trend, and management is buying. Analysts believe the share could perform by more than 100%. At least it is certainly not expensive. Investors in AIXTRON are still waiting for the upward trend. Speculation has stalled the share price recovery for the time being. However, there are also optimistic voices from analysts.

time to read: 3 minutes | Author: Fabian Lorenz
ISIN: AIXTRON SE NA O.N. | DE000A0WMPJ6 , BASF SE NA O.N. | DE000BASF111 , EXASOL AG NA O.N. | DE000A0LR9G9

Table of contents:


    Exasol: Share has potential and is building momentum

    While the AI high-flyer stocks NVIDIA and Super Micro Computer are consolidating, attention is turning to promising second-tier stocks. One of these is a German AI share: Exasol. Artificial intelligence has to be trained with data. This is where Exasol comes into play as a specialist in data analysis (Big Data) with its high-performance software, Espresso. With Exasol Espresso, companies - whose 200 customers include T-Mobile and Adidas - can transform vast amounts of data into faster, deeper and more cost-effective insights. After a challenging 2022 and 2023, the share has found a bottom; turnover in the share has recently risen, and it is building momentum. The Exasol share is currently trading at around EUR 2.70, and the market capitalization is around EUR 72 million. According to analysts at M.M Warburg, this is favourable, and they recommend the share as a "Buy" with a price target of EUR 6.30.

    There are good arguments for a further rise in the share price. Among other things, Exasol presented its own AI tools for data analysis in February and is expected to break even in its operating business (EBITDA) in the current year. In addition, the Management Board and Supervisory Board have bought shares in recent weeks. Sales successes were also achieved in the financial industry in the first quarter. Exasol extended existing contracts or concluded new contracts with a total of four customers from Europe and the US. The annual recurring revenue volume (ARR) is expected to be around EUR 1 million, meaning that Exasol is well on track to further increase its ARR revenue of EUR 41.7 million from 2023 and become profitable as expected. And then, of course, there is also the chance of a lucrative takeover bid from a tech giant such as Oracle or SAP in the current environment.

    AIXTRON: Customers about to jump ship?

    The AIXTRON share is still struggling to build momentum. The shock after the surprisingly weak forecast for the current year seems too deep for investors. The gentle countermovement after the share price fall was stifled by rumors that AIXTRON could lose important customers such as Wolfspeed and ON Semiconductor.

    Analysts believe that the equipment manufacturer in the semiconductor sector can achieve significantly higher share prices. Jefferies recently confirmed its "Buy" recommendation for the AIXTRON share. The Company's technology in the area of equipment for the production of silicon carbide semiconductor wafers is outstanding. Therefore, the recent speculations about market share losses should not be overestimated. Instead, analysts expect AIXTRON to achieve a market share of over 50% in this segment in the coming year**. The analysts' price target is EUR 50. The share is currently trading at just over EUR 23.

    BASF: Is the share running out of steam?

    BASF shares are currently being driven by positive momentum. The DAX-listed company's shares have risen by a strong 25% in just two months. It is now trading at EUR 54 again, marking a 52-week high. However, analysts believe that the stock may be running out of steam. According to recent analyst comments, UBS remains the most optimistic. The analysts see a fair value of the BASF share at EUR 61. While Berenberg has upgraded the share from "Hold" to "Buy", the price target of EUR 58 has almost been reached.

    Goldman Sachs rates BASF as "Neutral". The price target of EUR 53 is at the current level. Jefferies is bearish on BASF, setting a price target of EUR 43, significantly below the current level. For this reason, the chemical company's shares are only an "Underperform" for the analysts.


    Exasol's recovery is just beginning. Positive company news, share purchases by management and the leap in profitability suggest that the AI share price will continue to rise. In contrast, AIXTRON will likely need more time and positive company news to convince investors to buy in. The BASF share has been convincing in recent weeks, but the air is slowly getting thin.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Fabian Lorenz

    For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.

    About the author



    Related comments:

    Commented by Fabian Lorenz on October 1st, 2025 | 07:20 CEST

    1,000% not enough for D-Wave? 70% price potential for Zalando! Will Walmart partner MiMedia's stock now take off?

    • cloud
    • Digitization
    • computing
    • ecommerce
    • Technology

    After a meteoric 1,000% rise in just 12 months, D-Wave Quantum shares continue to attract attention. Analysts are significantly raising their price targets - is the next short squeeze already looming? Meanwhile, bargain hunters should take a closer look at MiMedia. The Walmart partner's shares have halved since July, yet the Company is making strong progress in expanding its cloud platform. A rebound of up to 100% back to its previous high is possible. And in Europe, Zalando is back on investors' radar. Analysts see up to 70% upside potential, while the chart is also looking more favorable again. However, the weak consumer climate continues to weigh on business sentiment.

    Read

    Commented by Carsten Mainitz on October 1st, 2025 | 07:05 CEST

    Almonty Industries, Gerresheimer, BASF – It is not too late yet!

    • Mining
    • Tungsten
    • Defense
    • chemicals
    • Pharma

    The race for critical high-tech goods and raw materials is already underway. The COVID-19 pandemic painfully highlighted the downsides of a globally interconnected economy. China's export ban on critical raw materials is currently having a double impact, as the country dominates the market. This effect is expected to continue to intensify in the future as demand continues to rise dynamically while supply increases only slowly. This provides a strong tailwind for raw material producers, but poses significant challenges for companies in other sectors.

    Read

    Commented by André Will-Laudien on September 30th, 2025 | 07:35 CEST

    High-tech super boom! 1,000% no problem—here is more from D-Wave, NetraMark and Palantir!

    • Biotechnology
    • AI
    • Digitization
    • hightech
    • computing
    • Software

    Artificial intelligence (AI) is currently revolutionizing drug development by analyzing enormous amounts of data in a very short time and making clinical trials much more targeted. Modern AI systems make it possible to select drug candidates with precision and predict the potential success of a therapy with a high degree of accuracy. Companies like NetraMark are already using these technologies profitably. Players such as D-Wave and Palantir are also among the pioneers of the new AI-driven economy and have seen their share prices rise by over 1,000%. Expectations for further growth are virtually limitless. The advent of quantum computer technology also marks the beginning of a new chapter in ultra-fast data processing. For forward-looking investors, this opens up attractive entry opportunities in dynamically expanding future markets. Those who bet on the right players early on can benefit from this change to an above-average extent.

    Read